Federico Lucchetti

Federico Lucchetti

Auto-generated profile, based on publicly available information

Federico Lucchetti

Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
FLFederico Lucchetti
Federico Lucchetti
ECEdgar Céléreau
Edgar Céléreau
Pascal SteulletPascal Steullet
Pascal Steullet
YAYasser Alemán-Gómez
Yasser Alemán-Gómez
PHPatric Hagmann
Patric Hagmann
PKPaul Klauser
Paul Klauser
Network science has mapped brain structural and functional organization, yet capturing metabolic contrast remains a major gap in connectomics. Using fast, high-resolution 3D whole-brain proton magnetic resonance spectroscopic imaging ( 1 H-MRSI), we derive a within-subject metabolic connectome in 51 healthy subjects, defined as pairwise correlations among five metabolites (tCr, tNAA, Glx, Ins, Cho) across gray-matter parcels. Results show stability, consistency and replicability, including validation in an independent sample ( N = 13) scanned at a different site. A dimensionality reduction analysis shows that the leading metabolic similarity mode forms a continuous caudal-to-rostral gradient across gray-matter regions. We show that this progression is reflective of a balance between local metabolic homogeneity and global metabolic diversity, and can be summarized by a principal path through the metabolic network. While the most metabolically active regions overlap with structural hubs, overall metabolic similarity aligns weakly with tractography-based structural connectivity but more closely with cytoarchitectonic similarity and gene co-expression matrices. These findings introduce the metabolic similarity gradient as a signature of the brain’s biochemical organization and position MRSI as a biologically grounded dimension for connectomics in health and disease.

24 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ECEdgar Céléreau
Edgar Céléreau
FLFederico Lucchetti
Federico Lucchetti
YAYasser Alemán-Gómez
Yasser Alemán-Gómez
DDDaniella Dwir
Daniella Dwir
MCMartine Cleusix
Martine Cleusix
PKPaul Klauser
Paul Klauser
Advances in three-dimensional magnetic resonance spectroscopic imaging (3D-MRSI) allow for the high-resolution mapping of multiple neurometabolites throughout the entire brain in vivo and within clinically compatible time frames. Leveraging this capability, we created a voxel-based pipeline that corrects and spatially normalizes whole-brain maps of total N-acetylaspartate (tNAA), myo-inositol (Ins), choline compounds, glutamate + glutamine, and creatine + phosphocreatine. We examined 2 different 3D-MRSI dataset: first, a clinical sample of adolescents and young adults at risk for psychosis (n= 21) meeting DSM-5 criteria for Attenuated Psychosis Syndrome (APS) or Schizotypal Personality Disorder (SCZT), and age-/sex-matched healthy controls (n =13); and second, a non-clinical sample of adolescents (n = 61) scanned on a different site. The objective of the study was threefold: first, to assess the reproducibility of 3D-MRSI measures across datasets and scanning sites; second, to validate the feasibility of whole-brain, voxel-based analyses on 3D-MRSI data; and third, to test the sensitivity of this approach. Metabolite distributions showed reproducible regional variation in standard space between the two independent samples and scanning sites (r ranging from 0.82 to 0.99). Relative to controls, at-risk participants exhibited higher tNAA levels in frontal grey matter; the SCZT subgroup additionally displayed widespread cortical and subcortical elevations of Ins levels compared with both APS and controls. Voxel-based analyses of structural (i.e., gray and white matter volumes or densities) and diffusion (i.e., generalized fractional anisotropy) parameters yielded no significant differences between patients and controls. These preliminary findings suggest that high-resolution 3D-MRSI may be sensitive enough to detect subtle neurometabolic alterations at the group level in the early stages of psychotic disorders when structural or diffusion measures show no difference. High-resolution whole-brain metabolic mapping may have the potential to help with early identification of young people at risk for psychosis or other mental disorders.

13 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
FLFederico Lucchetti
Federico Lucchetti
ECEdgar Celereau
Edgar Celereau
Pascal SteulletPascal Steullet
Pascal Steullet
YAYasser Aleman-Gomez
Yasser Aleman-Gomez
PHPatric Hagmann
Patric Hagmann
PKPaul Klauser
Paul Klauser
Network science has revolutionized our understanding of brain organization by revealing self-organizing patterns underlying its structural and functional connectivity. However, capturing metabolic contrast remains a challenge, leaving a critical gap in connectomics. Using advanced 3D whole-brain proton MR spectroscopic imaging with high spatial resolution and shortened acquisition times, we constructed the first human brain metabolic connectome in 51 healthy subjects, validated on an independent cohort (N=12) scanned at a different site. Our pipeline generates consistent and reliable metabolic similarity matrices. Upon further analysis, metabolic similarity networks display distinct topological features, notably a smoothly varying gradient delineating functionally and spatially distinct yet integrated brain regions via connector hubs. Although metabolic hubs correlate with structural hubs, overall alignment with structural connectivity is poor. However, metabolic organization aligns more closely with cytoarchitectonic and genetic co-expression patterns, suggesting a neurodevelopmental origin. This work puts forward the metabolic similarity gradient as a hallmark of the brain's overarching biochemical organization, and provides a foundation for incorporating metabolite imaging into the broader domain of connectomics and its potential applications in health and disease.

17 June 2026 in Imaging Neuroscience
Verified
Journal Article
Open access
ECEdgar Céléreau
Edgar Céléreau
FLFederico Lucchetti
Federico Lucchetti
YAYasser Alemán-Gómez
Yasser Alemán-Gómez
DDDaniella Dwir
Daniella Dwir
MCMartine Cleusix
Martine Cleusix
PKPaul Klauser
Paul Klauser
Advances in three-dimensional magnetic resonance spectroscopic imaging (3D-MRSI) allow for the high-resolution mapping of multiple neurometabolites throughout the entire brain in vivo and within clinically compatible time frames. Leveraging this capability, we created a voxel-based pipeline that corrects and spatially normalizes whole-brain maps of total N-acetylaspartate (tNAA), myo-inositol (Ins), choline compounds (Cho), glutamate + glutamine (Glx) and creatine + phosphocreatine (tCr). We examined 2 different 3D-MRSI dataset: first, a clinical sample of adolescents and young adults at risk for psychosis (n = 21) meeting DSM-5 criteria for Attenuated Psychosis Syndrome (APS) or Schizotypal Personality Disorder (SCZT), and age-/sex-matched healthy controls (n = 13); and second, a non-clinical sample of adolescents (n = 61) scanned on a different site. The objective of the study was threefold: first, to assess the reproducibility of 3D-MRSI measures across datasets and scanning sites; second, to validate the feasibility of whole-brain, voxel-based analyses on 3D-MRSI data; and third, to test the sensitivity of this approach. Metabolite distributions showed reproducible regional variation in standard space between the two independent samples and scanning sites (r ranging from 0.82 to 0.99). Relative to controls, at-risk participants exhibited higher tNAA levels in frontal grey matter; the SCZT subgroup additionally displayed widespread cortical and subcortical elevations of Ins levels compared with both APS and controls. Voxel-based analyses of structural (i.e., gray and white matter volumes or densities) and diffusion (i.e., generalized fractional anisotropy) parameters yielded no significant differences between patients and controls. These preliminary findings suggest that high-resolution 3D-MRSI may be sensitive enough to detect subtle neurometabolic alterations at the group level in the early stages of psychotic disorders when structural or diffusion measures show no difference. High-resolution whole-brain metabolic mapping may have the potential to help with early identification of young people at risk for psychosis or other mental disorders.

16 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
FLFederico Lucchetti
Federico Lucchetti
ECEdgar Celereau
Edgar Celereau
RJRaoul Jenni
Raoul Jenni
JLJean-Baptiste LEDOUX
Jean-Baptiste LEDOUX
SEStephan Eliez
Stephan Eliez
PKPaul Klauser
Paul Klauser
Magnetic resonance spectroscopic imaging (MRSI) enables non-invasive mapping of neu-rometabolites levels across the human brain. Although spectral fitting and metabolite quan-tification are increasingly supported by mature software tools, the downstream processing of quantified metabolite maps remains heterogeneous across laboratories. Here, we introduce MRSIPrep, an open-source, modular, and reproducible post-quantification framework for whole-brain MRSI. MRSIPrep standardizes quality control, tissue correction, spatial nor- malization, atlas projection, and derivative generation from quantified metabolite maps and associated quality metrics. The framework produces voxelwise, regional, and connectomics-ready outputs together with automated quality-control reports. We describe the architecture of MRSIPrep and demonstrate its utility for reproducible MRSI analysis across datasets,acquisition protocols, and downstream applications.

6 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ECEdgar Céléreau
Edgar Céléreau
FLFederico Lucchetti
Federico Lucchetti
Pascal SteulletPascal Steullet
Pascal Steullet
ZSZoé Schilliger
Zoé Schilliger
YAYasser Alemán-Gómez
Yasser Alemán-Gómez
PKPaul Klauser
Paul Klauser
Sex differences in brain disorders span age at onset, symptom profiles, disease course and treatment response, and may partly reflect underlying differences in cellular metabolism. Indeed, in vivo evidence of sex-related neurometabolic variation remains sparse, with heterogenous and conflicting findings. Using fast high-resolution whole-brain three-dimensional magnetic resonance spectroscopic imaging, we mapped five brain metabolites in three independent cohorts of healthy participants (total n = 114). In a discovery sample of adolescents scanned at 3 Tesla (3T) (n = 61), males showed higher total N-acetylaspartate (tNAA) across widespread gray matter regions. Regional analyses further revealed opposing sex patterns with a complementary higher total creatine (tCr) observed in females, motivating examination of their ratio as an integrative metabolic index. The tNAA/tCr ratio was consistently higher in males in the discovery sample and this finding was replicated across two independent young-adult samples (3T, n = 26; 7T, n = 27), with a widespread gray and white matter distribution. This tNAA/tCr ratio may link neuronal mitochondrial metabolism with cellular energy buffering, positioning it as a potential index of bioenergetic balance relevant for conditions showing both sex differences and altered neurometabolism, notably multiple sclerosis, Alzheimer disease, and psychosis. Together, these findings reveal a reproducible, distributed metabolic sexual dimorphism in the human brain, and underscore the importance of accounting for sex-specific neurometabolic profiles in studies of brain health and disease.